儿童哮喘评分预测急诊初始支气管扩张剂治疗后住院的诊断准确性研究
这项多中心观察性研究纳入1238名2-18岁在澳大利亚四家急诊接受至少一剂支气管扩张剂的儿童,评估十种常用哮喘评分预测住院的能力。所有评分每增加一分均与住院 odds 增加相关,但无评分达到Youden指数≥50%。
要点
- 十种儿童哮喘评分均未达到预设的AUC ROC≥0.80,预测住院能力有限。
- 所有评分每增加一分与住院 odds 增加相关,但无评分达到Youden指数≥50%。
核心结论
- 本研究中评估的哮喘评分均未达到预设的主要结局AUC ROC≥0.80。
研究设计与样本
- 多中心观察性研究,纳入1238名2-18岁在澳大利亚四家急诊接受至少一剂支气管扩张剂的儿童,由培训研究护士在初始治疗前后采集观察数据计算十种哮喘评分。
主要发现
- 1238名患者中792名(64.0%)为男性,中位年龄3岁(IQR 2-6),513名(41.4%)符合住院标准。
- 调整OR分析显示所有10种哮喘评分每增加一分均与住院 odds 增加相关(p=<0.001)。
- 无哮喘评分达到Youden指数≥50%。
关键数值与推荐
- 主要结局阈值:AUC ROC≥0.80。
- 次要结局阈值:Youden指数≥50%。
- 调整OR分析中所有评分每增加一分与住院 odds 增加相关(p=<0.001)。
临床怎么用
- 临床使用哮喘评分预测急诊初始支气管扩张剂治疗后住院决策时需谨慎,因本研究中无评分达到预设判别标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The ability of paediatric asthma scores to predict admission following initial bronchodilator therapy has not been comprehensively evaluated. METHODS: A multicentre observational study including children aged 2-18 years who received at least a single dose of bronchodilator following presentation to four Australian emergency departments (EDs). Observations were obtained by trained research nurses before and after initial treatment to calculate ten common asthma scores (Pediatric Respiratory Assessment Measure (PRAM), Siriraj Clinical Asthma Score (SiCAS), Clinical Asthma Score (CAS), Acute Asthma Intensity Research Score (AAIRS), Modified Pulmonary Index Score (MPIS), Pulmonary Index Score (PIS), Pediatric Asthma Score (PAS), Pediatric Asthma Severity Score (PASS), Woods and Downs and Pulmonary Score (WDCAS)). Primary outcome was determining the global ability of scores to discriminate between those admitted and discharged, assessed by an area under receiver operating curve (AUC ROC) ≥0.80. Secondary outcomes included adjusted ORs and the ability to provide an adequate balance between sensitivity and specificity (defined as Youden Index ≥50%). RESULTS: Of the 1238 patients enrolled, 792 (64.0%) were male, median age was 3 years (IQR 2-6), and 513 (41.4%) met the admission criteria. None of the asthma scores demonstrated an AUC ROC ≥0.80, with the four best performing (MPIS, SCAS, PIS and PAS) scoring between 0. 70 and 0.73. Results for adjusted OR analysis indicated that each one-point increase was associated with increased odds of admission for all 10 asthma scores (p=<0.001). No asthma score achieved a Youden Index ≥50%. CONCLUSION: None of the asthma scores assessed in this study met the predetermined primary outcome of an AUC ROC ≥0.80.
引用
- Gray C, Armit L, Babl FE, et al. Diagnostic accuracy study assessing the ability of paediatric asthma scores to predict admission following initial emergency department bronchodilator therapy: a Clinical Asthma Scoring systems in Paediatric Emergency (CASPER) study. Arch Dis Child. 2026. PMID: 42392843. doi:10.1136/archdischild-2026-330613
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。